Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China · Delayed Price · Currency is CNY 16.34
-0.05 (-0.31%)
Oct 17, 2025, 3:04 PM CST
SHE:000403 Revenue
Pacific Shuanglin Bio-pharmacy had revenue of 611.83 million CNY in the quarter ending June 30, 2025, a decrease of -12.66%. This brings the company's revenue in the last twelve months to 2.5 billion, down -9.10% year-over-year. In the year 2024, Pacific Shuanglin Bio-pharmacy had annual revenue of 2.65 billion with 14.00% growth.
Revenue (ttm)
2.50B
Revenue Growth
-9.10%
P/S Ratio
6.20
Revenue / Employee
950.66K
Employees
2,635
Market Cap
15.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | 325.96M | 14.00% |
| Dec 31, 2023 | 2.33B | -76.47M | -3.18% |
| Jan 1, 2023 | 2.41B | 433.45M | 21.98% |
| Jan 1, 2022 | 1.97B | 921.80M | 87.80% |
| Jan 1, 2021 | 1.05B | 134.28M | 14.67% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |